X-ray group sees profitable future

In the regional portfolio, Bede announced its interim figures and as a whole they were well received by the market.

In the regional portfolio, Bede announced its interim figures and as a whole they were well received by the market.

Bede specialises in the design and manufacture of X-ray measurement tools and software for the semi-conductor industry.

Chairman Stuart McIntosh reported a pretax loss of £1.5m. However, the group's order book increased to £2.6m, compared with £1.6m for the same period last year and further orders are expected in the next quarter. Most of the orders have been placed by new customers.

Bede also announced that it hopes to return to profitability in the fourth quarter of this financial year. The news gave a much needed boost to its share price, which surged up 5.29% to close at 7.37p.

Elsewhere, the release of a good set of figures by George Wimpey gave a boost to the housebuilding sector.

It will be followed by regional housebuilder Bellway, which is scheduled to announce a trading update to the market today (Wed) and Barratt Developments released an update on July 24.

Bellway and Barratt Developments participated in the rally, moving moderately higher by 23p and 12p to finish the day at 1197p and 981p respectively.

One of the best performances in the regional portfolio was recorded by local medical devices company Immunodiagnostic Systems (IDS).

IDS specialises in the design and manufacture of an extensive range of immunoassay test kits for clinical and research laboratories, but is best known for its expertise in developing tools to aid in the diagnosis of bone and calcium dysfunction.

The Boldon company's share price moved strongly higher over the session to close 6p or 4% better at 154.5p.

Anthony Peart is an investment manager of the Wise Speke division of Brewin Dolphin Securities Ltd

Journalists

David Whetstone
Culture Editor
Graeme Whitfield
Business Editor
Mark Douglas
Newcastle United Editor
Stuart Rayner
Sports Writer